Evidence map›Paper›PMID 28770463›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2017

Joint SNMMI-ASNC expert consensus document on the role of

Panithaya Chareonthaitawee, Rob S Beanlands, Wengen Chen, Sharmila Dorbala, Edward J Miller, Venkatesh L Murthy, David H Birnie, Edward S Chen, Leslie T Cooper, Roderick H Tung and 7 more

Abstract readConsensus Statement
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Beyond the Biopsy: Imaging Frontiers in Cardiac Sarcoidosis.Cardiology research and practice · 2026
    Review
  7. Prevalence of Persistent Cardiovascular and Pulmonary Abnormalities on PET/MRI and DECT Imaging in Long COVID Patients.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  8. Review
  9. AI-enabled CT-guided end-to-end quantification of total cardiac activity in 18FDG cardiac PET/CT for detection of cardiac sarcoidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2025
    Article
  10. Review
  11. Innovations in Imaging:Current cardiology reports · 2024
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Cardiac sarcoidosis treated with nonsteroidal immunosuppressive therapy.International journal of cardiology. Heart & vasculature · 2024
    Article
  17. Article
  18. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2024
    Article
  19. Imaging of Pulmonary Sarcoidosis-A Review.Journal of clinical medicine · 2024
    Review
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Panithaya ChareonthaitaweeDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA. chareonthaitawee.panithaya@mayo.edu.
Rob S BeanlandsDivision of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Wengen ChenDepartment of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Sharmila DorbalaDivision of Nuclear Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Edward J MillerSection of Cardiovascular Medicine, Yale University, New Haven, CT, USA.
Venkatesh L MurthyDivision of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA.
David H BirnieDivision of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Edward S ChenSchool of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Leslie T CooperDepartment of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, USA.
Roderick H TungDivision of Cardiology, University of Chicago Medicine, Chicago, IL, USA.
Eric S WhiteDivision of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA.
Salvador Borges-NetoDepartment of Radiology and Nuclear Medicine, Duke University, Durham, NC, USA.
Marcelo F Di CarliDivision of Nuclear Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Robert J GroplerDepartment of Radiology, Mallinckrodt Institute of Radiology, St. Louis, MO, USA.
Terrence D RuddyDivision of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Thomas H SchindlerSchool of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Ron BlanksteinDivision of Nuclear Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fluorodeoxyglucose F18RadiopharmaceuticalsCardiomyopathiesConsensusDefibrillators, ImplantableHumansPacemaker, ArtificialPositron Emission Tomography Computed TomographyPrognosisSarcoidosisFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.